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Abstract 
Background: Malaria in pregnancy is an immense public health problem with at least 50 million pregnant women 
living in malaria endemic areas. To prevent malaria and its complications in pregnancy the World Health Organiza‑
tion recommends the use of intermittent preventive treatment sulfadoxine–pyrimethamine (IPTp‑SP), the use of 
insecticide‑treated nets (ITNs), and effective case management. In most malaria endemic countries in Africa, 40 % of 
pregnant women sleep under ITNs. In Cameroon, about 90 % of pregnant women receive the first dose of SP, while 
64 % take the complete dose. Following the 2011 mass‑campaign of free distribution of ITNs coupled with routine 
ANC distribution of ITN and adoption of IPTp in Cameroon, little has been done to assess the effectiveness of both 
interventions outside of Yaoundé, the capital city. This study sought to assess the usage and effectiveness of IPTp‑SP 
and ITNs on malaria in pregnancy.
Methods: The research was a cross‑sectional hospital‑based study that included 410 pregnant women attending 
antenatal clinics in the Buea Health District. Capillary blood samples were collected to check malaria parasite by 
microscopy and haemoglobin levels by microhaematocrit technique.
Results: A prevalence of 13.4 and 41.7 % was detected for malaria and anaemia, respectively. The Overall coverage of 
ITN was 32.4 % while that of ITPp was 63.2 %. Malaria prevalence was least (7.2 %) amongst women using both IPTp‑
SP and ITN while those with no intervention had the highest malaria prevalence of 18.6 % (χ2 = 6.188; P = 0.103). Of 
the women with malaria, 12.73 % were using ITN and had taken at least one dose of SP, 38.18 % had taken at least one 
dose IPTp only, 10.91 % were using only ITN and 38.18 % were not using any preventive measure. There was a differ‑
ence in anaemia status within the different intervention groups (χ2 = 8.673; P = 0.034). Pregnant women using both 
interventions were less associated to malaria (OR = 0.341, 95 % CI = 0.138–0.841) compared to those using only one 
control method.
Conclusion: Repeated doses of SP in combination with ITN use are effective in reducing malaria parasitaemia and 
improving haemoglobin level of pregnant women.
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Background
Malaria is a mosquito-borne disease of humans and other 
animals caused by parasitic protozoans of the genus Plas-
modium. It is transmitted through the bite of an infected 
female Anopheles mosquito. According to the World 
Health Organization (WHO), an estimated 214 million 
new cases of malaria occurred worldwide in 2015 and 
438,000 malaria deaths with the African region account-
ing for most global cases of malaria (88 %) [1].
Malaria in pregnancy is an immense public health 
problem with at least 50 million pregnant women living 
in malaria endemic areas [2]. Pregnant women are more 
likely than non-pregnant women to become infected 
with Plasmodium falciparum and, once infected, there 
is a tendency towards increased severity of disease [3, 4] 
caused in part by the transient depression of cell-medi-
ated immunity that occurs during pregnancy [5].
Under conditions of high transmission, there is 
increased P. falciparum parasite density in placental 
and peripheral blood, which is higher in first, compared 
to later, pregnancies [6]. This epidemiological pattern 
for P. falciparum has been recognized for several years, 
with higher density in early pregnancy, which increases 
if untreated, and then decreases as gestation progresses 
[7]. In stable high transmission areas, almost all primi-
gravidae, if unprotected, are likely to be infected in early 
pregnancy and approximately half of these would remain 
so by the time of delivery if untreated. In multigravidae, 
especially in those with higher parities, parasite density 
is significantly reduced due to the acquisition of parity-
specific immunity [8]. The effects of malaria on pregnant 
women differ with various factors, such as the woman’s 
level of immunity, her gravidity, the trimester of preg-
nancy, and the presence or absence of co–morbidity [6, 
9].
Malaria in pregnancy can have serious consequences 
for the mother, fetus, and newborn child, yet the harm-
ful effects are preventable with interventions that are 
inexpensive and cost-effective and have been available 
for over two decades [10–12]. The WHO in 2004 recom-
mended a package of intermittent preventive treatment 
in pregnancy (IPTp) with sulfadoxine-pyrimethamine 
(SP) and use of insecticide-treated nets (ITNs), together 
with effective case management of clinical malaria and 
anaemia.
In Cameroon, this policy was adopted and imple-
mented by the Ministry of Public Health in 2004 imme-
diately after WHO recommendations and consisted of 
at least three free SP doses between the 16th and the 
36th weeks of pregnancy alongside use of ITNs. These 
interventions are commonly delivered in antenatal clin-
ics (ANC) through collaboration between malaria and 
reproductive health programmes [1]. According to the 
world malaria report in 2011, in most malaria endemic 
countries in Africa, 40 % of pregnant women sleep under 
ITNs. In Cameroon, about 90  % of pregnant women 
receive the first dose of SP, while about 64  % take the 
complete dose [13]. Following the 2011 mass-campaign 
of free distribution of ITNs coupled with routine ANC 
distribution of ITN and adoption of IPTp in Cameroon 
little has been done to assess the effectiveness of these 
interventions with potentials of being efficacious, easy 
to administer, safe and tolerable [4, 12, 14], has not been 
fully evaluated together, so the combined effects of IPTp 
and ITN is still lacking information. This study was, 
therefore, designed to assess the usage and effectiveness 
of ITN and IPTp on malaria and anaemia in pregnancy. It 
was hypothesized that women using both IPTp plus ITN 
in pregnancy will be better protected against malaria and 
anaemia than women using only one of the prevention 
option (IPTp only, ITN only) or not using any at all.
Methods
Ethical considerations
Ethical clearance was obtained from the Institutional 
Review Board of the Faculty of Health Sciences at the 
University of Buea and administrative authorization 
obtained from the Regional Delegation of Public Health, 
South West Region and from the District Medical Officer 
of Buea; permission was sought from the different health 
facilities. Informed consent was obtained from the 
women prior to their interview and sample collection.
Study area
The study was carried out in the Buea Health District 
(BHD) that comprises of both rural and urban commu-
nities. It has seven health areas with a total of 21 rec-
ognized health facilities. Six of whom were randomly 
selected using ballot (Mount Mary Hospital, Buea Road 
HC, Regional Hospital Buea, Solidarity Health Founda-
tion, Molyko HC, Mile 16 IHC) from four health areas 
(Molyko, Buea Road, Muea and Bokwango).
Study design and study population
The study was cross-sectional hospital-based and 
included all pregnant women attending antenatal ser-
vices in the BHD. HIV positive women on cotrimoxazole 
were excluded to avoid confounder on IPT. A total of 410 
pregnant women participated in the study from April to 
July 2014.
Data collection
A simple structured questionnaire was used to interview 
participants in English; however, for all illiterate women, 
questions were translated into “Pidgin” (Creole). The 
questionnaire sought to obtain demographic data and 
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data on IPTp-SP and ITN use. Hospital records of par-
ticipants were used to confirm IPTp use and the dos-
age. The Roll Back Malaria (RBM) partnership indicator 
for ITN use, which is based on the proportion of preg-
nant women who slept under an ITN the previous night 
[15]), was equally utilized to determine ITN usage. The 
women were then placed into different groups; IPTp-SP 
plus ITN use, IPTp only, ITN only and no intervention. 
The term ITN in this study was referred to nets that had 
been treated with insecticide and needed ongoing treat-
ment or long-lasting insecticide nets which are the most 
frequently distributed types of net in Africa [15]. A sam-
ple size of 408 had been estimated by the Watson formula 
[16] to provide the desired outcome at 5 % precision, 95 % 
confidence level and an estimated usage rate for IPTp of 
90 % [13] and ITN 61 % [17] giving an average response 
rate of 75.5 %, that was used to calculate the sample size.
Sample collection and processing
Blood samples were collected by finger prick after clean-
ing the finger with alcohol. A drop of blood was placed 
on a grease-free microscope slide and a thick blood film 
was made and stained for 15  min using 10  % Giemsa. 
More blood was collected in heparinized micro haema-
tocrit tubes for determination of haemoglobin levels 
using packed cell volume (PCV). The Giemsa-stained 
thick smear were examined microscopically under 100X 
objective (oil immersion) using an Olympus microscope. 
Slides were considered positive when asexual forms 
and/or gametocytes of any Plasmodium species were 
observed on the blood films. A slide was declared nega-
tive after examining at least 100 high power field with-
out any Plasmodium species, as described in [18, 19]. 
The microhaematocrit tubes were then centrifuged in a 
microhaematocrit centrifuge for 5 min at 10,000 rpm and 
read using the Hensin microhaematocrit reader accord-
ing to the manufacturer instruction. PCV levels less than 
30 % (10 g/dl) were classified as anaemia [20] since HB is 
a third of PCV.
Data analysis
A template of the questionnaire was prepared using Epi-
Info 3.5.3 and the data entered, cleaned and exported 
to SPSS version 20 (IBM SPSS, Chicago, IL, USA). Data 
was summarized into means and standard deviations and 
percentages were used in the evaluation of the descrip-
tive statistics. Differences in Proportions were compared 
using the χ2 test. Means of Haemoglobin levels and 
malaria parasitaemia were compared using the Kruskall-
Wallis test. Logistic regression was used to compare 
malaria and anaemia status in the different intervention 
groups with no intervention group as control or refer-
ence group. The level of significance was set to p < 0.05.
Results
Characteristics of study participants
A total of 410 pregnant women were enrolled among 
which 28 (6.8  %) were from Muea, 45 (11.0  %) from 
Molyko, 265 (64.5  %) from Buea Road and 72 (17.6  %) 
from Bokwaongo. The participants were aged 14–48 with 
a mean age of 26.54  ±  4.87. The gestation ages ranged 
from 8 to 41 weeks with a mean of 27.48 ± 6.95. Primi-
gravidae constituted 24 % and multigravidae made 33.2 % 
of the study participants. Pregnant women in their third 
trimester were more likely to use IPTp (53.7  %) than 
those in the second trimester while women in their first 
trimester were less likely to use ITNs than the others. 
Women >25 years were more likely to use both interven-
tion. More information about the demographic charac-
teristics is displayed in Table 1.
Coverage of IPTp and ITN
The coverage of ITN was 32.4 % while the coverage of ITPp 
was 63.2 %, with pregnant women greater than 25 years of 
Table 1 Demographic characteristics of study population





 ≤20 38 (9.3) 6 (4.5) 19 (7.3)
 21–25 142 (34.6) 30 (22.6) 92 (35.5)
 >25 230 (56.1) 97 (72.9) 148 (57.2)
Educational level
 Primary level 91 (22.2) 36 (27.1) 56 (21.6)
 Secondary/high 
school
182 (44.4) 65 (48.9) 108 (41.7)
 Tertiary 137 (33.4) 32 (24.1) 95 (36.7)
Gravidity
 Primigravid 152 (37.1) 28 (21.1) 94 (36.3)
 Secundigravid 122 (29.8) 45 (33.8) 76 (29.3)




135 (33) 21 (15.8) 88 (34)
 Business 123 (30) 43 (32.3) 79 (30.5)
 Civil servant 76 (18.5) 35 (26.3) 50 (19.3)
 House wife/farmer 76 (18.5) 34 (25.6) 42 (16.2)
Number of ANC visits
 First visit 88 (21.5) 25 (18.8) 5 (1.93)
 Second visits 131 (32) 39 (29.3) 81 (31.3)
 Three or more visits 191 (46.6) 69 (51.9) 173 (66.8)
Trimester
 First 19 (4.6) 5 (3.8) 0 (0)
 Second 238 (58) 73 (54.9) 120 (46.3)
 Third 153 (37.3) 55 (41.4) 139 (53.7)
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age more likely to use both interventions. Of the 55 preg-
nant women with parasitaemia, 7 (12.73 %) were using ITN 
and had taken at least one dose of SP, 21 (38.2 %) had taken 
at least one dose IPTp, 6 (10.9 %) were using only ITN and 
21 (38.2 %) used none of the interventions (SP or ITN).
Prevalence of malaria and anaemia
Out of the 410 women who participated in the study 55 
(13.4 %) had malaria. Pregnant women attending ANC for 
the first time had a higher prevalence of malaria (18.2 %) 
though the difference was not statistically significant 
(χ2 = 2.335, P = 0.311). Pregnant women using no malaria 
intervention were found to have the highest malaria preva-
lence (18.6 %) and mean parasite density (Fig. 1) compared 
to those using ITN only, IPTp only and both ITN and IPT 
(Table  2); the differences among them was not signifi-
cant for both prevalence and mean parasitaemia, respec-
tively (χ2 = 6.188, P = 0.103 and χ2 = 6.973, P = 0.073). 
The prevalence of anaemia was 41.7 %. The mean HB was 
10.42 ± 1.48 and HB ranged from 6 to 15.70 g/dl. There was 
a significant difference in anaemia prevalence (χ2 = 8.673, 
P  =  0.034) and mean haemoglobin levels (χ2  =  10.453, 
P = 0.015) in the different intervention (Fig. 2).
Effects of the usage of IPT‑SP and ITN on malaria 
prevalence and haemoglobin levels
Those without intervention (Table  2) had the high-
est malaria prevalence (18.6  %), highest GMPD 
(461 ± 11114) while those using only ITN had the least 
GMHB with a significant difference within the groups 
(χ2 = 10.453, P = 0.015).
Effects of IPT‑SP and ITN on malaria prevalence
Pregnant women with at least two doses of SP and using 
ITN are better protected than women with just one SP 
dose in addition to ITN use (Fig.  3a), likewise, women 
using only IPT-SP have least malaria prevalence (7.70 %) 
with three successive doses of SP.
Effectiveness of IPT and ITN on malaria control
Using no intervention as control and comparing it with 
ITN, IPT and IPT  +  ITN (Table  2), those using IPT 
combined with ITN were less associated to malaria 
(OR  =  0.341, CI  =  0.138–0.841), followed by those 
using IPT only (OR  =  0.643, CI  =  0.333–1.244) while 
those using only ITN were more associated to malaria 
(OR = 0.876, CI = 0.323–2.373).
Fig. 1 Influence of the different interventions on mean parasitaemia
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Discussion
Malaria and anaemia in pregnancy are important pub-
lic health problems in the Buea Health District (BHD). 
These problems contribute significantly to high mater-
nal and child mortality. It is well known that pregnant 
women living in many parts of sub-Saharan Africa have 
an increased risk of malaria infection, but limited data 
have been reported on the impact of IPTp and ITN in 
combination for pregnant women in Cameroon. The 
goal of this study was to assess the usage the impact of 
IPTp-SP and ITN use on malaria in pregnant women in 
the BHD.
A prevalence of 13.4 and 41.7  % was recorded for 
malaria and anaemia respectively. The prevalence for 
malaria was lower than the 32.7 % reported in 2005 [21] 
in a similar area. This reduction as the years go by may 
be due to the systematic free distribution of bed nets and 
IPT-SP to pregnant women. The prevalence of anaemia 
was lower than that reported earlier in other areas of the 
country [13, 22]. This could be due the free distribution 
Table 2 Effects of the usage of the different interventions on malaria, parasitaemia and haemoglobin levels
GMPD is geometric mean of parasite density and GMHB is geometric mean of Haemoglobin levels
Factor Form of intervention Total N = 410 Significance level
IPT + ITN  
N = 97
IPT only  
N = 164




Malaria prevalence 7 (7.2 %) 21 (12.8 %) 6 (16.7 %) 21 (18.6 %) 55 (13.4 %) χ2 = 6.188 P = 0.103
GMPD 123 ± 694 137 ± 653 915 ± 2549 461 ± 11,114 261 ± 7056 χ2 = 6.975 P = 0.073
Anaemia prevalence 46 (47.4 %) 54 (32.9 %) 17 (47.2 %) 54 (47.8 %) 171 (41.7 %) χ2 = 8.673 P = 0.034
GMHB 10.34 ± 1.66 10.67 ± 1.40 10.10 ± 1.26 10.22 ± 1.47 10.42 ± 1.48 χ2 = 10.453 P = 0.015
Fig. 2 Effects of the different interventions on anaemia status
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of iron, folic acid and other blood giving supplement to 
pregnant women attending ANC, coupled with the fact 
that the coverage of IPTp-SP is on the rise in the country 
where at least 90 % of pregnant women have been shown 
to receive the first dose [13], which can reduce malaria-
related anaemia.
The coverage of ITN was 32.4 % which less than what 
was reported in Sudan and Tanzania [17, 23] with main 
reasons advanced by the women for not using nets being 
hot weather, absent of mosquito, in conveniences which 
is similar to some of the reasons seen in a meta analysis 
[12]. The coverage of ITPp was 63.2 % which is less than 
that reported in Sudan [17] with main reason being late 
ANC start.
In this study, malaria prevalence was higher in the 
IPTp-SP plus ITN group at first SP dose compared to 
those at second and third dose (Fig. 3a). This could be 
attributed to the effectiveness of SP drug to clear most 
parasitaemia in the pregnant women and the additional 
protection provided by bed nets, which has also been 
shown in the meso-endemic area of the Thai-Burmese 
border [24] and in the Gambia [25] to reduce maternal 
malaria and anaemia. The slightly higher prevalence of 
malaria in pregnant women who took three successive 
doses of SP in addition to ITN use could be as a result 
of possible development of resistance of the parasites 
to SP in some women and also may be due to the long 
interval between SP doses. The was a systematic reduc-
tion in prevalence of malaria with increasing doses of 
SP with those using only IPTp (Fig.  3b) which shows 
the effectiveness and impact of SP in malaria control. 
Multigravid women using only ITN had the highest 
malaria prevalence (Fig.  3c) than secundigravid and 
primigravid women, this is different from other stud-
ies which found primigravid women were more suscep-
tible due to the production of antibodies in successive 
pregnancies that prevent parasite sequestration in the 
placenta [26].
Those not using any intervention and those using only 
ITN had the least geometric mean of HB (Table  2 and 
Fig. 2) with a significant different in GMHB (χ2 = 10.453, 
P  =  0.015) within the different interventions simply 
because most of those in this group were attending ANC 
late and for their first time and therefore had not received 
any of the supplements given to pregnant women to pre-
vent anaemia.
This study also shows that pregnant women not using 
any intervention had the highest geometric mean of 
parasite density. This could be due to the lack of any bar-
rier or prophylactic measure to prevent malaria, such as 
ITN and IPTp whose effectiveness and efficacy has been 
shown [27]. Those using both forms of interventions were 
less associated to malaria compared to the other interven-
tion groups (OR =  0.341, 95  % CI =  0.138–0.841). This 
is probably because of the ability of SP to clear malaria 
parasite and the effectiveness of ITN to prevent malaria 
though SP might have cover up for inconsistent use of 
ITN. This could be confirmed from the fact that those 
using IPT only were less associated to malaria than those 
using ITN only (OR = 0.876, 95 % CI = 0.323–2.373).
Conclusion
There was a decrease in peripheral parasitaemia with 
improved HB levels following increasing doses of SP/
IPTp in addition to the use of ITN. The use of both 
interventions (IPT +ITN) reduces malaria morbid-
ity compared to using a single intervention. Sensiti-
zation of pregnant women on the combined used of 
ITNs and IPT-SP during pregnancy would be pivotal to 
achieving significant results in the struggle to reduce 
malaria-related complication in pregnancy. This would 
be achieved by encouraging pregnant women to attend 
ANC early during pregnancy, in order to be drilled 
on the benefits of taking complete doses of SP. This 
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Fig. 3 Effects of IPT‑SP and ITN on malaria prevalence
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undertake mass awareness campaigns to educate moth-
ers on the importance of using both IPT and ITN during 
pregnancy.
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